Results 141 to 150 of about 1,734 (194)

Does treatment with antiviral medication affect mortality among immunocompetent individuals with cytomegalovirus reactivation? A systematic review and meta-analysis. [PDF]

BMC Infect Dis
Wu AY, Tsai MC, Newton S.
europepmc   +1 more source

Evaluating Real-World Experience With Maribavir for Treatment of Refractory/Resistant Cytomegalovirus in Renal Transplant Recipients. [PDF]

Clin Transplant
Beechar VB, Phadke VK, Pouch SM, Mehta AK, Karadkhele G, Larsen CP, Woodworth MH.   +6 more
europepmc   +1 more source

Efficacy of antimicrobials in preventing resistance in solid organ transplant recipients: A systematic review of clinical trials. [PDF]

World J Transplant
Ardila CM, Yadalam PK, Ramírez-Arbelaez J.   +2 more
europepmc   +1 more source

[Maribavir effectively treated three patients with human herpesvirus-6B infection after allogeneic hematopoietic stem cell transplantation]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Jin CW, Li S, Wang LX, Huang JY, Hu XX, Zhang ZL.   +5 more
europepmc   +1 more source

Population pharmacokinetics and exposure-response relationships of maribavir in transplant recipients with cytomegalovirus infection. [PDF]

J Pharmacokinet Pharmacodyn
Song IH, Chen G, Hayes S, Farrell C, Jomphe C, Gosselin NH, Sun K.   +6 more
europepmc   +1 more source